# Transverse Myelitis Related to SARS-CoV-2 Vaccines

> **NCT05178264** · — · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 580 (actual)

## Conditions studied

- Vaccine Adverse Reaction

## Interventions

- **DRUG:** SARS-CoV-2 vaccines

## Key facts

- **NCT ID:** NCT05178264
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-10
- **Primary completion:** 2021-12-10
- **Final completion:** 2021-12-10
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05178264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05178264, "Transverse Myelitis Related to SARS-CoV-2 Vaccines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05178264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
